TESARIL M 50/1000 Tablets – Dual Action for Diabetes Management with cardiac protection
TESARIL M 50/1000 Tablets – Sitagliptin 50mg + Metformin 1000mg tablet contains Sitagliptin and Metformin in combination, primarily used to treat type-2 diabetes.
Sitagliptin is a DPP-4 inhibitor that suppresses the generation of glucagon, which lowers hepatic glucose output, and raises the levels of active incretins, improving glucose-dependent insulin release. Metformin increases peripheral tissue insulin sensitivity while lowering hepatic glucose synthesis. By reducing gastrointestinal pain, its prolonged-release version improves patient adherence and lowers HbA1c levels. The combination works well as a treatment for type 2 diabetes because it offers complete glycemic control.
Recommended by specialists:
✅Diabetologist : For diagnosing and treating diabetes mellitus.
✅General Physician : For management of type 2 diabetes.
✅Endocrinologists : To prevent cardiometabolic diseases.
Key benefits of Sitagliptin 50mg + Metformin 1000mg Tablets – TESARIL M 50/1000 Tablets
✅Synergistic Action : Combination of Sitagliptin (DPP-4 inhibitor) and Metformin (biguanide) to target glucose control from two angles, minimizing the risk of hypoglycemia.
✅Minimal Side Effects: It supports balanced glucose levels with better tolerability than other diabetes treatments.
✅Weight loss: Unlike other anti-diabetic medication it helps in weight neutralization and weight loss beneficial for patients with overweight issues.
✅Cardioprotective action: Along with diabetes control it offers cardioprotective action, and manages Cardiometabolic diseases in long-term use of medication.
Indications
✅Type 2 Diabetes Mellitus
✅Cardiometabolic Management